EP 1888557 A2 20080220 - (5Z)-5-(6-QUINOXALINYLMETHYLIDENE)-2-Ý(2,4,6-TRICHLOROPHENYL)AMINO¨-1,3-THIAZOL-4(5H)-ONE
Title (en)
(5Z)-5-(6-QUINOXALINYLMETHYLIDENE)-2-Ý(2,4,6-TRICHLOROPHENYL)AMINO¨-1,3-THIAZOL-4(5H)-ONE
Title (de)
(5Z)-5-(6-QUINOXALINYLMETHYLIDEN)-2-Ý(2,4,6-TRICHLOROPHENYL)AMIN-1,3-THIAZOL-4(5H)-ON
Title (fr)
(5Z)-5-(6-QUINOXALINYLMETHYLIDENE)-2-Ý(2,4,6-TRICHLOROPHENYL)AMINO¨-1,3-THIAZOL-4(5H)-ONE
Publication
Application
Priority
- US 2006022383 W 20060608
- US 68867605 P 20050608
Abstract (en)
[origin: WO2006133381A2] Invented is the compound (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,4,6-trichlorophenyl)amino]-1 ,3-thiazol-4(5H)-one, and pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are pharmaceutical compositions containg this compound, methods of preparing this compound and pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are methods of using this compound as an inhibitor of hYAK3 proteins.
IPC 8 full level
A61K 31/498 (2006.01); C07D 401/00 (2006.01)
CPC (source: EP US)
A61P 7/06 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 35/02 (2017.12 - EP); C07D 417/06 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
HR
DOCDB simple family (publication)
WO 2006133381 A2 20061214; WO 2006133381 A3 20070705; EP 1888557 A2 20080220; EP 1888557 A4 20120215; JP 2008543769 A 20081204; US 2008194466 A1 20080814
DOCDB simple family (application)
US 2006022383 W 20060608; EP 06784679 A 20060608; JP 2008515940 A 20060608; US 91312106 A 20060608